No Prescription |
 |
 | ||
|
ALDACTONE Generic Spironolactone |
|
| ||
No Prescription » Prescription Drugs 1 » ALDACTONE Generic Spironolactone Spironolactone is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes heart attacks and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (e.g. congestive heart failure) by removing excess fluid and improving symptoms such as breathing problems.This medication is also used to treat low potassium levels and conditions in which the body is making too much of a natural chemical (aldosterone).Spironolactone is known as a "water pill" (potassium-sparing diuretic).OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This medication has also been used to treat excessive hair growth (hirsutism) in women with polycystic ovary disease.How to use Spironolactone OralTake this medication by mouth as directed by your doctor. If stomach upset occurs take it with food or milk. It is best to take your dose early in the day (before 6 p.m.) to prevent having to get up during the night to urinate. Consult your doctor or pharmacist if you have any questions.Dosage is based on your medical condition and response to therapy. In children the dosage is also based on body weight.Take this medication regularly in order to get the most benefit from it. Remember to use it at the same time(s) each day as directed. It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick.Take this medication exactly as prescribed. Do not increase your dose take it more often than prescribed or stop using this medicine without first consulting your doctor. Your condition may become worse when the drug is suddenly stopped.Inform your doctor if your condition worsens (e.g. if you notice an increase in your routine blood pressure readings).Spironolactone Oral is used to treat the following:Diagnostic Test for Primary Hyperaldosteronism Low Amount of Potassium in the Blood High Blood Pressure Chronic Heart Failure Accumulation of Fluid Resulting from Chronic Heart Failure Fluid in the Lungs due to Chronic Heart Failure Accumulation of Fluid caused by Cirrhosis of the Liver Accumulation of Fluid caused by Kidney Disease Visible Water Retention AscitesSpironolactone Oral may also be used to treat:Disease of Ovaries with Cysts Diastolic Heart Failure Male Pattern of Hair Distribution or Hirsutism in a Woman Buy ALDACTONE Generic Spironolactone and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About ALDACTONE Generic Spironolactone: Product Type: Prescription Drugs 1 ALDACTONE ( Generic Spironolactone ) ALDACTONE (Generic Spironolactone) Generic Spironolactone 100mg Tabs 30 (3 x 10) 100mg Tabs 60 ( 6 x 10 ) 25mg Tabs 30 (3 x 10) 100mg 48 ( 3 x 16 )Tabs 100mg 16 Tabs 25mg 20 Tabs 25mg 60 ( 3 x 20 )Tabs Generic Spironolactone ALDACTONE
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
